Oruka Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Oruka Therapeutics, Inc. (ORKA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents61.5837.4342.4553.3649.078.366.61
Short-Term Investments314.070.000.000.000.000.000.00
Cash & Short-Term Investments375.6537.4342.4553.3649.078.366.61
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets1.220.160.251.060.900.120.17
Total Current Assets376.870.0042.7054.4249.978.486.78
Non-Current Assets
Property, Plant & Equipment (Net)1.040.260.370.490.450.030.02
Long-Term Investments18.070.000.000.000.000.000.00
Other Non-Current Assets0.040.010.020.020.010.020.02
Total Non-Current Assets19.150.270.390.500.460.060.05
Total Assets396.020.0043.0954.9250.438.546.83
Current Liabilities
Accounts Payable3.460.540.962.572.680.930.64
Short-Term Debt0.210.000.000.000.000.000.00
Accrued Liabilities9.370.000.000.000.000.000.00
Other Current Liabilities9.370.100.170.930.820.000.00
Total Current Liabilities13.040.641.133.503.500.930.79
Non-Current Liabilities
Long-Term Debt0.760.200.280.380.410.000.00
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.760.200.280.380.410.000.00
Total Liabilities13.800.841.413.883.910.930.79
Stockholders' Equity
Common Stock0.040.000.000.000.000.000.00
Retained Earnings-83.72-188.74-183.40-173.48-154.15-144.42-138.93
Accumulated Other Comprehensive Income-0.040.000.000.000.000.000.00
Additional Paid-in Capital463.020.00225.06224.51200.67152.02144.97
Shares Outstanding37.440.000.000.000.000.000.00
Total Stockholders' Equity382.220.0041.6751.0446.527.616.03
Total Liabilities & Equity396.020.0043.0954.9250.438.546.83